| Literature DB >> 26470404 |
.
Abstract
The Food and Drug Administration (FDA) is issuing a final order to reclassify shortwave diathermy (SWD) for all other uses, a preamendments class III device, into class II (special controls), and to rename the device "nonthermal shortwave therapy'' (SWT). FDA is also making a technical correction in the regulation for the carrier frequency for SWD and SWT devices.Mesh:
Year: 2015 PMID: 26470404
Source DB: PubMed Journal: Fed Regist ISSN: 0097-6326